Proteome Sciences (PRM)

 

PRM Share PerformanceMore

52 week high20.2500 25/07/16
52 week low3.5000 03/03/17
52 week change -14.9000 (-76.41%)
4 week volume14,395,920 26/06/17

Media for (PRM)

Presenter: Christopher Pearce
30/05/2014

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Proteome schedules interim results release date

Proteome Sciences has confirmed that the Company will announce its interim results for the six months ended 30 June on...

Notice of Results

RNS Number: 7216K Proteome Sciences PLC 11 July 2017 Proteome Sciences plc ("Proteome Sciences" or the "Company") Notice of Results Proteome Sciences will announce its interim results for the six months ended 30 June 2017 on 25 July 2017. For further information: Proteome Sciences plc Dr Jeremy Haigh, Chief Executive Officer Tel: +44 (0)20 7043 2116 Dr Ian P...

Holding(s) in Company

RNS Number: 7329J Proteome Sciences PLC 30 June 2017 TR-1:NOTIFICATION OF MAJOR INTEREST IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii PROTEOME SCIENCES 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights NO An...

Proteome Sciences achieves research milestone

Proteome Sciences said Randox Laboratories Ltd presented the first results from a prospective trial using its Rapid Stroke A...

Stroke Diagnostic- Research Milestone Achieved

RNS Number: 6681J Proteome Sciences PLC 30 June 2017 Proteome Sciences plc ("Proteome Sciences" or the "Company") Stroke Diagnostic Presentation at EuroMedLab 2017 - Research Milestone Achieved We are pleased to announce that Randox Laboratories Ltd, ("Randox") presented the first results from a prospective trial using its Rapid Stroke Array at the EuroM...

New Registered Address

RNS Number: 6479H Proteome Sciences PLC 12 June 2017 Proteome Sciences plc ("Proteome Sciences" or the "Company" New Registered Address Proteome Sciences plc (AIM:PRM) is pleased to announce that its corporate headquarters have moved from Cobham to new premises in central London, and the Board has approved that from 12 June 2017 the new registere...

Second Price Monitoring Extn

RNS Number: 5939H Proteome Sciences PLC 08 June 2017 Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this security would still have executed more than a pre-determined pe...

Price Monitoring Extension

RNS Number: 5934H Proteome Sciences PLC 08 June 2017 Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders entered in an individual security's auction call before the execution...

Fundamental DataMore

EPS-0.96
Dividend yield0 %

Equity Research (PRM)

edison investment research
Proteome Sciences plc
29/01/2015
Edison Investment Research is terminating coverage on Proteome Sciences (PRM). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now...
edison investment research
Proteome Sciences plc
17/11/2014
Proteome Sciences signed its first major biomarker service contract in September. This followed on from the data from the 1,148-patient Alzheimer’s disease (AD) study, which could lead to a blood-...

Latest discussion posts More

Users' HoldingsMore

Users who hold Proteome Sciences also hold..
LLOYDS GRP.23%
BP15%
BARCLAYS15%
VODAFONE GRP.13%
ROYAL BANK SCOT11%

Codes & Symbols

ISINGB0003104196
SymbolsPRM, LSE:PRM, PRM.L, PRM:LN, LON:PRM, XLON:PRM